by Raynovich Rod | Feb 22, 2020 | Biopharmaceuticals, Macro
2/24 Update at close; A big sell-off on coronavirus pandemic fears with major indices down about 3%. Teledoc Health (TDOC) up 0.66% to $114.26. Our top pick from JPM 2019. Biopharma winners: GILD up 4.6%, REGN up 5.5% on safety concerns with Novartis drug. MRNA up...
by Raynovich Rod | Jan 31, 2020 | Biopharmaceuticals, Macro
Update-1 2/3…3:30p EST… Biopharma stocks firm up after a bad week Large caps are strong with Gilead Sciences (GILD) up over 5% on a story about an experimental antiviral therapy for coronavirus China. GILD is one of the leading antiviral companies for...
by Raynovich Rod | Jan 6, 2020 | Biopharmaceuticals, Macro
Update-1 1/9/20 “Sigh of Relief” rally for second day -Don’t Fight the FED Dont confuse a momentum rally with fundamental analysis as we are at new highs with market PEs>18. Large cap biiopharmas are at new highs Mid-cap 2%+ winners today: ACAD,...
by Raynovich Rod | Dec 9, 2019 | Biopharmaceuticals, Macro
Update-1 …12/12/19…China Deal Announcement Boosts Dow S&P and NASDAQ. IBB up 0.68%, XBI up 0.58%, XLV up 0.93%. Large cap leaders: ABBV ALXN BMY, Chips, energy, financials strong; real estate weak. 10 year yield moves up to 1.894% =========== Early...
by Raynovich Rod | Nov 10, 2019 | Biopharmaceuticals, Macro
Biotech and Healthcare Stocks Notch -Up with Bullish Tape Action Since we called the early October reversal for healthcare and biotech stocks we have seen great gains of 5-7% with more gains ahead assuming good clinical news and M&A. Friday we saw a good tape...
by Raynovich Rod | Nov 7, 2019 | Biopharmaceuticals, Macro
Biotech Action Today is Muddled-Midday Selloff presumably on “Recycling” of China Trade Chatter Uncertainty Remains on Trade War and Tariffs Little rally in gene therapy stocks; 1% + Winners include QURE RGNX SRPT; XBI up only 0.26% as rally faded. Mixed...
by Raynovich Rod | Oct 15, 2019 | Biopharmaceuticals, Macro
Update-1 Large caps were mixed but our top picks are doing well: ABBV,BMY,MRK,RHHBY. But bad news from JNJ and BA may have curbed buyer’s sentiment. United Health (UNH) off Mondays lows of $220 to $245. In summary it looks like a good time fo adding larger cap...
by Raynovich Rod | Oct 2, 2019 | Biopharmaceuticals, Clinical Diagnostics and Tools, Macro
Update-2 10/4 Broad Rally day: all major averages up 1.4%, NAZ at 7982. Risk back on. But biotech lags major indices IBB up 0.75%, XBI up 0.21% to $76.82. Better trade for biotech has been large caps: ABBV, AMGN, MRK,RHHBY VRTX. Mid-cap movers: BLUE up 3.97%, GWPH up...
by Raynovich Rod | Sep 24, 2019 | Biopharmaceuticals, Macro
With biotech in a funk this timely article from Barron’s should help. Barron’s to the Rescue: Future of Biotech, article offers picks from a new Roundtable (above link may not open because requires subscription) Some of the picks ASND, MDCO,MGTX,NVTA,RGNX,...
by Raynovich Rod | Aug 19, 2019 | Biopharmaceuticals, Clinical Diagnostics and Tools, Macro
Update -3 Bearish trends in biopharma continue with both the IBB and XBI down with 30 min of trading to go. We will do a review of the healthcare sector later this week continuing the theme after the AACC of the need for diversification within healthcare e.g. medtech,...
Reuters Healthcare